Skip to main content
Skip to footer
Opens in a new tab
Search
Home
About UK NEQAS
Our Team
Sustainability
EQA/PT Programmes
Trial Schedules
Programme Flyers
New Participant Information
Publications
Flow Cytometry Programmes
Molecular Haemato-oncology Programmes
News
FAQs
Contact Us
Home
About UK NEQAS
Our Team
Sustainability
EQA/PT Programmes
Trial Schedules
Programme Flyers
New Participant Information
Publications
Flow Cytometry Programmes
Molecular Haemato-oncology Programmes
News
FAQs
Contact Us
Home
|
Assessing the impact of the 2017 European LeukemiaNet recommendations on FLT3 allelic ratio calculation and reporting in acute myeloid leukaemia
